echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Shanghai's newly added medical insurance negotiation drug dupilimumab injection is listed on the Internet

    Shanghai's newly added medical insurance negotiation drug dupilimumab injection is listed on the Internet

    • Last Update: 2022-05-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On February 15, the Shanghai Sunshine Pharmaceutical Purchasing Network released the "Detailed List of Some Newly Added Drugs for Negotiation on Medical Insurance (The Third Batch)".
    The specifications and packaging are - 1.
    14ml (200mg) * 2 pieces/box, type 1 transparent glass bottle, prefilled syringe with safety device for needle protection

    .

    In addition, the "Shanghai Pharmaceutical Procurement Service and Supervision Information System" will push the drug information to the hospital, which will take effect on February 17, 2022
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.